Evotec SE (EVO) Insider Trading Activity

NASDAQ$1.55
Market Cap
$550.53M
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
542 of 849
Rank in Industry
30 of 48

EVO Insider Trading Activity

EVO Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
–
Sells
$0
0
–

Related Transactions

About Evotec SE

Evotec SE operates globally as a dedicated partner, specializing in the discovery and advancement of new pharmaceutical products for the biotechnology and pharmaceutical sectors. Its comprehensive research and development initiatives encompass a broad spectrum of medical areas, such as metabolic disorders (including diabetes and its complications), fibrosis, infectious conditions, central nervous system (CNS) diseases, oncology, pain management, inflammatory ailments, immunological dysfunctions, rare diseases, respiratory conditions, and …

Insider Activity of Evotec SE

Over the last 12 months, insiders at Evotec SE have bought $0 and sold $0 worth of Evotec SE stock.

On average, over the past 5 years, insiders at Evotec SE have bought $0 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 392 shares for transaction amount of $5,023 was made by BANK OF AMERICA CORP /DE/ (10 percent owner) on 2011‑10‑18.

List of Insider Buy and Sell Transactions, Evotec SE

2011-10-18SaleBANK OF AMERICA CORP /DE/10 percent owner
392
0.0003%
$12.75
$4,999
+2.53%
2011-10-18PurchaseBANK OF AMERICA CORP /DE/10 percent owner
392
0.0003%
$12.81
$5,023
+2.53%
Total: 2

EVO Institutional Investors: Active Positions

Increased Positions24+44.44%2M+16.08%
Decreased Positions22-40.74%2M-15.84%
New Positions18New531,853New
Sold Out Positions11Sold Out85,430Sold Out
Total Postitions56+3.7%10M+0.24%

EVO Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Mubadala Investment Co Pjsc$14,621.001.29%4.6M00%2025-09-30
Wellington Management Group Llp$4,547.000.4%1.43M+224,345+18.61%2025-09-30
Blackrock, Inc.$4,134.000.37%1.3M-40,263-3%2025-09-30
Dcf Advisers, Llc$3,813.000.34%1.2M+84,500+7.58%2025-09-30
Morgan Stanley$1,001.000.09%314,912-70,302-18.25%2025-09-30
Wcm Investment Management, Llc$955.000.08%300,277+2,370+0.8%2025-09-30
Pitcairn Co$514.000.05%161,769-99,412-38.06%2025-09-30
Abc Arbitrage Sa$420.000.04%132,057+93,097+238.96%2025-09-30
Citadel Advisors Llc$305.000.03%96,045+62,471+186.07%2025-09-30
Envestnet Asset Management Inc$241.000.02%75,711-15,953-17.4%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.